Position in PSNL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$133,317
New position
Shares Held
20,929
first reported quarter
Ownership
0.020%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Persistent Asset Partners Ltd holds $1,614,788 across 6 Diagnostics & Research names. PSNL ranks #5 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
2,643 | $455,917 | |
| 2 | ICLR |
Icon PLC
|
3,413 | $377,682 | |
| 3 | GH |
Guardant Health, Inc.
|
4,086 | $377,423 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
503 | $247,239 | |
| 5 | PSNL |
Personalis, Inc.
This page
|
20,929 | $133,317 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
6,689 | $23,210 |
All Filings in PSNL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $133,317 | 20,929 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||